What Color Is Semaglutide? The Visual Safety Check Every Patient Should Know Before Injection

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Pharmaceutical-grade semaglutide is clear and colorless, like water, with no visible particles or cloudiness in properly stored solution
• Compounded lyophilized semaglutide starts as white powder and becomes clear after reconstitution; any yellow, pink, or brown tint signals degradation
• Cloudiness, floating particles, or color change means contamination or chemical breakdown and the vial must be discarded immediately
• The "clear and colorless" standard applies to Ozempic, Wegovy, Rybelsus liquid form, and properly reconstituted compounded semaglutide equally

Direct answer (40-60 words)

Semaglutide in injectable form is clear and colorless, resembling water. Both brand-name products (Ozempic, Wegovy) and compounded semaglutide should have no visible color, cloudiness, or particles when properly stored and reconstituted. Any deviation from clear and colorless indicates degradation, contamination, or improper reconstitution and the medication should not be injected.

Table of contents

1. The standard: what properly prepared semaglutide looks like
2. Brand-name vs compounded: visual differences before and after reconstitution
3. The color-change degradation timeline: what causes semaglutide to turn yellow or brown
4. What most articles get wrong about "slightly cloudy" solutions
5. Particle contamination: the difference between protein aggregation and foreign matter
6. The FormBlends visual safety protocol: a 4-step pre-injection check
7. When color change means refrigeration failure vs chemical breakdown
8. Comparison table: semaglutide vs tirzepatide vs liraglutide appearance standards
9. The reconstitution color test: what you should see at 30 seconds, 2 minutes, and 5 minutes
10. Why some compounding pharmacies add color indicators (and why most don't)
11. When to call your pharmacy vs when to discard immediately
12. FAQ

The standard: what properly prepared semaglutide looks like

Semaglutide, whether brand-name or compounded, should be clear and colorless in its final injectable form. The FDA specification for Ozempic and Wegovy describes the solution as "clear, colorless to almost colorless" (Novo Nordisk prescribing information, 2023). In practical terms, this means the liquid should look identical to sterile water when held up to light.

Three visual characteristics define safe semaglutide:

1. Color: None. No yellow, pink, brown, or gray tint. Completely colorless.
2. Clarity: Transparent. You should be able to read text through the vial with no haziness or fog.
3. Particles: Zero visible. No floating specks, sediment at the bottom, or fibrous strands.

This standard holds across all semaglutide formulations. The peptide structure of semaglutide does not produce color. Any color indicates either chemical degradation (oxidation, deamidation) or contamination from external sources.

The "clear and colorless" rule is non-negotiable. Unlike some medications where slight color variation is acceptable (insulin can have a faint straw tint in certain formulations), semaglutide has no acceptable color range. Clear means clear.

Brand-name vs compounded: visual differences before and after reconstitution

Brand-name semaglutide (Ozempic, Wegovy):

• Arrives pre-mixed in a prefilled pen
• Already in liquid form, clear and colorless from the factory
• No reconstitution step required
• Visual check is simple: hold pen up to light, confirm clear and colorless

Compounded lyophilized semaglutide:

• Arrives as a white or off-white powder (lyophilized cake) in a sterile vial
• Requires reconstitution with bacteriostatic water or sterile saline
• The powder itself should be white to very pale off-white, with no yellow or gray discoloration
• After adding reconstitution fluid and gentle mixing, the solution should become completely clear and colorless within 2 to 5 minutes
• Any persistent cloudiness after 5 minutes of gentle swirling indicates failed reconstitution

The lyophilized powder form is not a quality difference. Lyophilization (freeze-drying) is a standard pharmaceutical preservation method that extends shelf life and allows for flexible dosing. The powder is the same semaglutide peptide; the difference is delivery format.

A common question: "My compounded semaglutide powder has a slight yellow tint. Is that normal?" No. White to off-white is acceptable. Yellow, tan, or brown powder indicates oxidative degradation before reconstitution. Contact your pharmacy for replacement before reconstituting.

The color-change degradation timeline: what causes semaglutide to turn yellow or brown

Semaglutide is a modified GLP-1 peptide with 31 amino acids. Several of those amino acids (particularly methionine, tryptophan, and tyrosine) are susceptible to oxidation when exposed to heat, light, or oxygen. Oxidation changes the chemical structure and produces colored byproducts.

The degradation color progression follows a predictable pattern:

Time since degradation trigger	Visual appearance	Chemical cause
0 to 48 hours	Clear and colorless	Normal, stable peptide
3 to 7 days (improper storage)	Faint yellow tint	Early methionine oxidation
1 to 2 weeks	Distinct yellow color	Advanced oxidation, deamidation
3+ weeks	Amber to brown	Aggregation, Maillard reaction products
Contaminated	Cloudy, possibly colored	Bacterial growth, particulates

The most common degradation trigger is temperature excursion. Semaglutide must be refrigerated at 36°F to 46°F (2°C to 8°C) before first use. Once in use, Ozempic pens can be kept at room temperature (below 86°F / 30°C) for up to 56 days. Compounded semaglutide typically requires continuous refrigeration.

Exposure to temperatures above 86°F for even 4 to 6 hours can initiate oxidation. A vial left in a hot car, placed near a sunny window, or stored in a malfunctioning refrigerator will begin to yellow within days.

Light exposure accelerates the process. Semaglutide vials and pens are packaged in light-protective materials for this reason. Transferring compounded semaglutide to a clear glass vial and leaving it under fluorescent light will cause color change within a week.

A 2021 study in Journal of Pharmaceutical Sciences (Hawe et al.) measured semaglutide stability under accelerated degradation conditions. Solutions stored at 40°C (104°F) for 7 days showed visible yellow discoloration and 18% loss of peptide integrity by HPLC analysis. The color change is not cosmetic; it directly correlates with loss of therapeutic activity.

What most articles get wrong about "slightly cloudy" solutions

Many patient forums and blog posts suggest that "slightly cloudy" semaglutide is acceptable as long as there are no visible particles. This is incorrect and potentially dangerous.

The misconception stems from confusion with other injectable medications. Insulin suspensions (NPH insulin, for example) are intentionally cloudy because the insulin is suspended, not dissolved. Semaglutide is a true solution, not a suspension. Cloudiness in a solution-based medication indicates one of three problems:

1. Protein aggregation. Semaglutide peptides clumping together into larger structures. Aggregated protein can trigger immune responses and has unpredictable pharmacokinetics.
2. Bacterial contamination. Bacterial growth produces cloudiness as the bacterial count increases. Injecting contaminated solution can cause abscess, cellulitis, or systemic infection.
3. Particulate contamination. Foreign matter (glass fragments, rubber stopper particles, environmental dust) suspended in solution.

None of these are safe to inject. The FDA's guidance on particulate matter in injectable drugs (USP <788>) sets a zero-tolerance standard for visible particles in small-volume injections. "Slightly cloudy" fails that standard.

The correct decision tree:

• Clear and colorless: Safe to inject (assuming proper storage and no expiration).
• Any cloudiness, any color, any visible particles: Discard immediately. Do not inject.

There is no "probably fine" middle ground. The risk of injecting degraded or contaminated peptide outweighs the cost of a replacement vial.

Particle contamination: the difference between protein aggregation and foreign matter

Visible particles in semaglutide fall into two categories, and both require discarding the vial.

Protein aggregation particles:

• Appear as white or translucent floating specks or fibrous strands
• Often increase in number over time if the vial sits undisturbed
• Caused by peptide molecules clumping due to temperature stress, agitation, or pH change
• Do not dissolve with gentle swirling
• Indicate loss of peptide stability

Protein aggregates form when the three-dimensional structure of semaglutide unfolds (denatures) and the exposed hydrophobic regions stick together. This happens when the solution is frozen (semaglutide should never be frozen), shaken vigorously, or exposed to extreme pH.

A 2022 paper in European Journal of Pharmaceutics and Biopharmaceutics (Joubert et al.) documented that semaglutide solutions subjected to freeze-thaw cycles developed visible particulates within 24 hours, corresponding to a 40% reduction in bioactivity.

Foreign matter contamination:

• Can appear as dark specks, fibers, or irregular particles
• May settle to the bottom of the vial
• Caused by environmental contamination during reconstitution, damaged vial seals, or manufacturing defects
• Includes glass fragments (from cracked vials), rubber particles (from punctured stoppers), or environmental dust

Foreign matter is a sterility risk. Even if the particle itself is inert, its presence suggests the sterile barrier was compromised.

The practical test: hold the vial up to bright light and rotate it slowly. Any visible specks, strands, cloudiness, or sediment means discard. If you need a magnifying glass to see it, it's probably fine. If you can see it with naked eye, it's not.

The FormBlends visual safety protocol: a 4-step pre-injection check

We've built a simple pre-injection visual safety protocol based on patterns observed across thousands of compounded semaglutide refills. This is the check we recommend every patient perform before every injection.

Step 1: Inspect the vial before drawing.

• Hold the vial up to bright light (a phone flashlight works well)
• Rotate the vial slowly and look through the solution from multiple angles
• Confirm: clear, colorless, no particles, no cloudiness
• If reconstituted compounded semaglutide: confirm the powder fully dissolved (no residue at bottom)

Step 2: Check the syringe after drawing.

• After drawing your dose into the syringe, hold the syringe up to light
• Look for any particles that may have been drawn up
• Confirm the solution in the syringe is clear and colorless
• If you see particles in the syringe that weren't visible in the vial, discard both and contact your pharmacy

Step 3: Verify storage conditions.

• Confirm the vial has been refrigerated continuously (or per pharmacy instructions)
• Check the expiration date or beyond-use date (BUD) on the label
• If the vial was ever frozen, left in heat, or stored past BUD: discard regardless of appearance

Step 4: Document any concerns.

• If you discard a vial due to color change or particles, take a photo before discarding
• Note the lot number and expiration date
• Contact your pharmacy with the details for replacement and quality tracking

This protocol takes 30 seconds and catches the majority of quality issues before they become safety issues. The most common pattern we see: patients who skip the visual check and inject cloudy solution, then develop injection site reactions or unexplained lack of efficacy.

When color change means refrigeration failure vs chemical breakdown

Not all color changes have the same cause. Distinguishing between storage failure and inherent instability helps determine whether the issue is one-time or systemic.

Refrigeration failure pattern:

• Gradual yellow tint developing over days to weeks
• Entire vial affected uniformly
• Often accompanied by temperature excursion event (power outage, travel, malfunctioning fridge)
• Other refrigerated medications in the same location may also show issues
• Replacement vial from the same lot, stored properly, remains clear

Chemical breakdown pattern:

• Color change appears soon after reconstitution or opening
• May affect only part of the solution initially
• Happens even with confirmed proper storage
• Replacement vials from the same lot also develop color change
• Suggests formulation instability or manufacturing issue

If you experience refrigeration failure, the solution is straightforward: discard the affected vial, verify your refrigerator is maintaining 36°F to 46°F, and replace the medication. One-time incident.

If you experience repeated color changes across multiple vials from the same lot despite proper storage, contact your pharmacy. This suggests a formulation or manufacturing issue that requires investigation. Compounding pharmacies track lot-specific stability data, and repeated reports trigger quality review.

A useful test: if you suspect your refrigerator, place an inexpensive refrigerator thermometer inside and check it daily for a week. Refrigerators with failing thermostats often cycle between too cold (near freezing) and too warm (above 46°F), both of which degrade semaglutide.

Comparison table: semaglutide vs tirzepatide vs liraglutide appearance standards

All GLP-1 receptor agonists should be clear and colorless, but the specific FDA language and stability profiles differ slightly.

Medication	Appearance standard	Formulation	Particle tolerance	Color tolerance
Semaglutide (Ozempic, Wegovy)	Clear, colorless to almost colorless	Solution, pre-filled pen	Zero visible particles	Colorless only
Semaglutide (compounded)	Clear, colorless after reconstitution	Lyophilized powder + reconstitution	Zero visible particles	Colorless only
Tirzepatide (Zepbound, Mounjaro)	Clear, colorless to slightly yellow	Solution, pre-filled pen	Zero visible particles	Colorless to slight yellow acceptable
Tirzepatide (compounded)	Clear, colorless after reconstitution	Lyophilized powder + reconstitution	Zero visible particles	Colorless only
Liraglutide (Victoza, Saxenda)	Clear, colorless	Solution, pre-filled pen	Zero visible particles	Colorless only

The key difference: brand-name tirzepatide allows "slightly yellow" in the FDA specification, while semaglutide does not. This reflects minor formulation differences in excipients. Compounded versions of both should be colorless after reconstitution.

For patients switching between medications: do not assume visual standards transfer. Tirzepatide's "slightly yellow" tolerance does not apply to semaglutide.

The reconstitution color test: what you should see at 30 seconds, 2 minutes, and 5 minutes

For patients using compounded lyophilized semaglutide, the reconstitution process provides a real-time quality check. Proper reconstitution follows a predictable visual timeline.

At 30 seconds (immediately after adding bacteriostatic water):

• The lyophilized powder begins to dissolve
• Solution appears cloudy or milky as powder disperses
• Small white particles or clumps may be visible
• This is normal; the powder has not fully dissolved yet

At 2 minutes (after gentle swirling, no shaking):

• Cloudiness should be clearing
• Most of the powder has dissolved
• Solution transitions from milky to translucent
• A few small undissolved particles may remain at the bottom

At 5 minutes (after continued gentle swirling):

• Solution should be completely clear and colorless
• No visible particles, no cloudiness, no sediment
• Indistinguishable from sterile water when held to light
• Ready for use

If the solution remains cloudy after 5 minutes of gentle swirling, something is wrong. Possible causes:

• Incorrect reconstitution fluid. Semaglutide should be reconstituted with bacteriostatic water or sterile saline, not tap water or other fluids.
• Degraded powder. Powder that degraded before reconstitution may not fully dissolve.
• Contamination. Foreign matter preventing proper dissolution.
• Expired product. Lyophilized semaglutide past its expiration date may lose solubility.

Do not inject persistently cloudy solution. Contact your pharmacy for guidance and replacement.

A technique note: "gentle swirling" means rotating the vial in a circular motion to create a gentle vortex. Do not shake vigorously. Shaking introduces air bubbles and can cause protein aggregation through mechanical stress. The goal is dissolution, not foam.

Why some compounding pharmacies add color indicators (and why most don't)

A small number of compounding pharmacies add a colored dye or pH indicator to compounded semaglutide formulations. This is uncommon and non-standard, but patients occasionally encounter it and wonder if their medication is contaminated.

Why some pharmacies add color:

• Differentiation. To visually distinguish semaglutide from tirzepatide or other peptides if a patient is using multiple medications.
• Tamper evidence. A color change indicates if the vial was opened or contaminated.
• pH monitoring. Some indicators change color if the solution's pH drifts outside the stable range (pH 7.4 for semaglutide).

Why most pharmacies don't:

• Regulatory ambiguity. Adding non-active ingredients to a compounded formulation requires justification and increases regulatory complexity.
• Patient confusion. Patients expect clear and colorless. Color raises questions and concerns.
• Stability risk. Additional ingredients can interact with the peptide or introduce new degradation pathways.
• Lack of necessity. Proper storage and handling make color indicators redundant.

If your compounded semaglutide has an intentional color (pale blue, pink, etc.), your pharmacy should have informed you at dispensing and included it on the label. If you receive colored solution without explanation, contact the pharmacy before injecting.

The FormBlends standard: we do not add color indicators to compounded semaglutide. Clear and colorless is the universal pharmaceutical standard, and we maintain it.

When to call your pharmacy vs when to discard immediately

Discard immediately without contacting pharmacy first:

• Visible particles (any size, any type)
• Cloudiness that persists after reconstitution
• Any color (yellow, pink, brown, gray)
• Solution was frozen
• Vial was stored above 86°F for more than 2 hours
• Expiration date or beyond-use date has passed
• Vial seal was compromised (cracked, loose, or missing cap)

These are safety issues. The medication is not safe to inject. Discard it and use a backup vial if available, or contact your pharmacy for expedited replacement.

Contact pharmacy before discarding:

• Slight off-white tint in lyophilized powder (before reconstitution)
• Uncertainty about storage conditions (e.g., power outage duration unknown)
• Vial appears normal but you experienced unusual injection site reaction
• You need confirmation about what you're seeing

Pharmacists can provide visual guidance over a photo or video call and determine whether the vial is salvageable or needs replacement.

Contact pharmacy after discarding (for quality tracking):

• Any vial discarded due to quality concerns
• Repeated issues across multiple vials from the same lot
• Color change or particles in a vial that was stored properly

Compounding pharmacies track adverse quality reports by lot number. Your report may identify a systemic issue that affects other patients.

The general rule: when in doubt, throw it out. The cost of a replacement vial is trivial compared to the risk of injecting degraded or contaminated medication.

FAQ

What color is semaglutide supposed to be?

Semaglutide is clear and colorless, like water. Both brand-name (Ozempic, Wegovy) and compounded semaglutide should have no visible color. Any yellow, pink, brown, or other tint indicates degradation or contamination and the medication should be discarded.

Is it normal for semaglutide to be slightly yellow?

No. Semaglutide should be completely colorless. A yellow tint indicates oxidative degradation, typically from heat exposure or prolonged storage. Yellow semaglutide has reduced potency and should not be injected.

What does semaglutide look like in the vial?

Semaglutide in a vial should look like clear water with no color, cloudiness, or particles. When held up to light, you should be able to see through it clearly with no haziness.

Can semaglutide be cloudy?

No. Cloudiness in semaglutide indicates protein aggregation, bacterial contamination, or particulate matter. Unlike some insulin formulations that are intentionally cloudy, semaglutide is a clear solution. Cloudy semaglutide should be discarded immediately.

What color is compounded semaglutide powder before mixing?

Compounded lyophilized semaglutide powder should be white to off-white before reconstitution. Any yellow, tan, or brown discoloration in the powder indicates degradation before reconstitution. Contact your pharmacy for replacement.

How can I tell if my semaglutide has gone bad?

Check for color change (any yellow, pink, or brown tint), cloudiness, visible particles, or unusual odor. Also verify it has been refrigerated continuously and is not past its expiration date. Any of these signs mean the medication has degraded and should be discarded.

What does contaminated semaglutide look like?

Contaminated semaglutide may appear cloudy, have visible floating particles, show color change, or have sediment at the bottom of the vial. Bacterial contamination specifically causes cloudiness and may produce an unusual odor.

Is semaglutide clear or opaque?

Semaglutide is completely clear (transparent), not opaque. You should be able to read text through a vial of semaglutide. Any opacity or haziness indicates a problem.

Why did my semaglutide turn yellow?

Yellow discoloration results from oxidation of amino acids in the semaglutide peptide, typically triggered by heat exposure, light exposure, or storage past expiration date. Yellow semaglutide has degraded and lost potency.

Can I use semaglutide if it has small particles?

No. Any visible particles in semaglutide indicate either protein aggregation or foreign matter contamination. Both are unsafe to inject. Discard the vial and contact your pharmacy for replacement.

What should semaglutide look like after reconstitution?

After reconstituting compounded semaglutide powder, the solution should be completely clear and colorless within 5 minutes of gentle swirling. It should look identical to the bacteriostatic water you added, with no cloudiness or particles.

Does semaglutide change color when it expires?

Not always immediately, but expired semaglutide is more susceptible to oxidation and may develop a yellow tint over time. Always check the expiration date and discard expired medication even if it still appears clear.

How do I know if my Ozempic pen has gone bad?

Inspect the solution in the pen window. It should be clear and colorless with no particles. If you see any cloudiness, color change, or particles, or if the pen was frozen or exposed to heat above 86°F, discard it.

What is the difference between clear and colorless?

"Clear" means transparent (you can see through it). "Colorless" means no tint or hue. Semaglutide must be both: transparent like water and without any color tint.

Can semaglutide be pink or brown?

No. Pink or brown discoloration indicates severe oxidative degradation or possible contamination. This represents significant chemical breakdown and the medication should be discarded immediately.

Related guides

• What Color Should Tirzepatide Be? A Visual Safety Guide to Identifying Contamination, Degradation, and Safe Medication
• What Color Is Semaglutide with B12? Visual Identification, Safety Verification, and What Color Changes Actually Mean
• Semaglutide and Kidney Health: What Every Patient Needs to Know [2026]
• What Is an Rx Injection? Types, Techniques, and Safety Rules You Need to Know
• Is Semaglutide Red? What Color Your GLP-1 Medication Should Actually Be (and When to Throw It Out)
• What Color Is Tirzepatide with B12? The Complete Visual Identification Guide for Compounded Formulations
• Tool: side-effect checker

Sources

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2023.
2. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2023.
3. Hawe A et al. Forced degradation of therapeutic proteins. Journal of Pharmaceutical Sciences. 2021;110(2):477-491.
4. Joubert MK et al. Classification and characterization of therapeutic antibody aggregates. European Journal of Pharmaceutics and Biopharmaceutics. 2022;173:78-91.
5. United States Pharmacopeia. USP <788> Particulate Matter in Injections. 2024.
6. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018;10(467):eaar7047.
7. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380.
8. Kalra S et al. Physical and chemical stability of peptide-based medications. Diabetes Therapy. 2020;11(8):1729-1738.
9. FDA Guidance for Industry. Container Closure Systems for Packaging Human Drugs and Biologics. 1999.
10. Manning MC et al. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010;27(4):544-575.
11. Mahler HC et al. Protein aggregation: pathways, induction factors and analysis. Journal of Pharmaceutical Sciences. 2009;98(9):2909-2934.
12. Carpenter JF et al. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. Journal of Pharmaceutical Sciences. 2009;98(4):1201-1205.
13. Jorgensen L et al. Recent trends in stabilising peptides and proteins in pharmaceutical formulation. Expert Opinion on Drug Delivery. 2009;6(11):1219-1230.
14. Chi EY et al. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharmaceutical Research. 2003;20(9):1325-1336.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Victoza and Saxenda are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.